Predictors of hospital length of stay after implantation of a left ventricular assist device: An analysis of the INTERMACS registry

Journal of Heart and Lung Transplantation

Volumn 33, Issue 7, 2014, Pages 682-688

  Cotts, William G ^a   McGee, Edwin C ^b   Myers, Susan L ^c   Naftel, David C ^c   Young, James B ^d   Kirklin, James K ^e   Grady, Kathleen L ^b  

^a ADVOCATE CHRIST MEDICAL CENTER   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e Kentucky   (United States)

Author keywords

continuous flow; heart failure; length of stay; mechanical circulatory support; ventricular assist device

Indexed keywords

ADULT; ARTICLE; ASSISTED CIRCULATION; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DEMOGRAPHY; FEMALE; HEART RIGHT ATRIUM PRESSURE; HOSPITAL DISCHARGE; HUMAN; LEFT VENTRICULAR ASSIST DEVICE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PATIENT SELECTION; PERIOPERATIVE PERIOD; PREDICTION; PREOPERATIVE EVALUATION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; TREATMENT OUTCOME; UREA NITROGEN BLOOD LEVEL; AGED; COHORT ANALYSIS; HEART ASSIST DEVICE; HEART FAILURE; MIDDLE AGED; MULTIVARIATE ANALYSIS; REGISTER; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; TIME;

ADULT; AGED; COHORT STUDIES; FEMALE; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT SELECTION; PERIOPERATIVE PERIOD; PREOPERATIVE PERIOD; REGISTRIES; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84904246791     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2014.02.022     Document Type: Article

References (21)

1. J.K. Kirklin, D.C. Naftel, and L.W. Stevenson et al. INTERMACS database for durable devices for circulatory support: first annual report J Heart Lung Transplant 27 2008 1065 1072
2. J.K. Kirklin, D.C. Naftel, and R.L. Kormos et al. Second INTERMACS annual report: more than 1,000 primary left ventricular assist device implants J Heart Lung Transplant 29 2010 1 10
3. J.K. Kirklin, D.C. Naftel, and R.L. Kormos et al. Third INTERMACS annual report: the evolution of destination therapy in the United States J Heart Lung Transplant 30 2011 115 123
4. J.K. Kirklin, D.C. Naftel, and R.L. Kormos et al. The Fourth INTERMACS annual report: 4,000 implants and counting J Heart Lung Transplant 31 2012 117 126
5. M.S. Slaughter, R. Bostic, and K. Tong et al. Temporal changes in hospital costs for left ventricular assist device implantation J Card Surg 26 2011 535 541
6. A.J. Boyle, D.D. Ascheim, and M.J. Russo et al. Clinical outcomes for continuous-flow left ventricular assist device patients stratified by pre-operative INTERMACS classification J Heart Lung Transplant 30 2011 402 407
7. E.S. Ketchum, A.J. Moorman, and D.P. Fishbein et al. Predictive value of the Seattle Heart Failure Model in patients undergoing left ventricular assist device placement J Heart Lung Transplant 29 2010 1021 1025
8. R.L. Kormos, J.J. Teuteberg, and F.D. Pagani et al. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes J Thorac Cardiovasc Surg 139 2010 1316 1324
9. L.W. Miller, K.E. Nelson, and R.R. Bostic et al. Hospital costs for left ventricular assist devices for destination therapy: lower costs for implantation in the post-REMATCH era J Heart Lung Transplant 25 2006 778 784
10. E.A. Rose, A.C. Gelijns, and A.J. Moskowitz et al. Long-term use of a left ventricular assist device for end-stage heart failure N Engl J Med 345 2001 1435 1443
11. K. Lietz, J.W. Long, and A.G. Kfoury et al. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection Circulation 116 2007 497 505
12. J. Butler, R. Howser, and P.M. Portner et al. Diabetes and outcomes after left ventricular assist device placement J Card Fail 11 2005 510 515
13. H.L. Lazar, M. McDonnell, and S.R. Chipkin et al. The Society of Thoracic Surgeons practice guideline series: blood glucose management during adult cardiac surgery Ann Thorac Surg 87 2009 663 669
14. J.L. Carson, P.M. Scholz, and A.Y. Chen et al. Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery J Am Coll Cardiol 40 2002 418 423
15. Y. Cohen, I. Raz, and G. Merin et al. Comparison of factors associated with 30-day mortality after coronary artery bypass grafting in patients with versus without diabetes mellitus. Israeli Coronary Artery Bypass (ISCAB) Study Consortium Am J Cardiol 81 1998 7 11
16. Z. Szabo, E. Hakanson, and R. Svedjeholm Early postoperative outcome and medium-term survival in 540 diabetic and 2239 nondiabetic patients undergoing coronary artery bypass grafting Ann Thorac Surg 74 2002 712 719
17. H.L. Lazar, S.R. Chipkin, and C.A. Fitzgerald et al. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events Circulation 109 2004 1497 1502
18. G. van den Berghe, P. Wouters, and F. Weekers et al. Intensive insulin therapy in critically ill patients N Engl J Med 345 2001 1359 1367
19. C. Garcia, A. Wallia, and S. Gupta et al. Intensive glycemic control after heart transplantation is safe and effective for diabetic and non-diabetic patients Clin Transplant 27 2013 444 454
20. M.S. Slaughter, F.D. Pagani, and J.G. Rogers et al. Clinical management of continuous-flow left ventricular assist devices in advanced heart failure J Heart Lung Transplant 29 suppl 2010 S1 39
21. D. Feldman, S.V. Pamboukian, and J.J. Teuteberg et al. The 2013 International Society for Heart and Lung Transplantation guidelines for mechanical circulatory support: executive summary J Heart Lung Transplant 32 2013 157 187